it can be, but it is rare.
Shy-Drager syndrome (Multiple system atrophy) is a rare, progressive neurological disorder with no known prevention method at this time. Research is ongoing to better understand the underlying causes and potential preventive measures. Treatment typically focuses on managing symptoms and improving quality of life.
Nail-patella syndrome (NPS), also known as hereditary osteo-onychodysplasia (HOOD), is a rare, genetically determined disease, which is inherited as a dominant trait. So yes, it is hereditary.
Currently, there is no safe or effective way to artificially remove entire chromosomes from human DNA to prevent genetic or hereditary diseases. Down syndrome, for example, is caused by an extra copy of chromosome 21, and simply removing this extra chromosome would be complex and could have unintended consequences. Research is ongoing to develop therapies that may one day help manage genetic conditions like Down syndrome.
While acute myeloid leukemia (AML) itself is not directly hereditary, there are inherited genetic conditions that can increase the risk of developing AML, such as Li-Fraumeni syndrome or Down syndrome. These inherited conditions can predispose individuals to developing AML later in life. However, most cases of AML occur sporadically without a clear genetic cause.
Yes, DNA is hereditary because it contains the genetic information that is passed down from parents to offspring. This genetic information determines an individual's traits and characteristics.
it can be, but it is rare.
it can be, but it is rare.
Try looking under Shy-Drager syndrome.
first described the condition in 1960
Shy-Drager syndrome is a degenerative neurological disorder that affects your brain and other parts of your central nervous system. It causes a drop in blood pressure when standing up, bladder dysfunction and other Parkinson's-like symptoms, such as slowness of movement, muscle rigidity and poor balance. Shy-Drager syndrome develops in adulthood, beginning at an average age of 50 years, and is gradually progressive and usually fatal. A rare condition, Shy-Drager syndrome occurs about two to three times more frequently in men. Shy-Drager syndrome is named after two researchers who first described it in 1960. It's commonly referred to as multiple system atrophy (MSA). http://www.mayoclinic.com/health/shy-drager-syndrome/DS00989/DSECTION=1
Shy-Drager syndrome (Multiple system atrophy) is a rare, progressive neurological disorder with no known prevention method at this time. Research is ongoing to better understand the underlying causes and potential preventive measures. Treatment typically focuses on managing symptoms and improving quality of life.
SDS was named for neurologists Milton Shy, M.D., from the National Institutes of Health, and Glenn Drager, M.D., from the Baylor College of Medicine, who first described the condition in 1960.
SDS was named for neurologists Milton Shy, M.D., from the National Institutes of Health, and Glenn Drager, M.D., from the Baylor College of Medicine, who first described the condition in 1960.
The cause of SDS is unknown. Symptoms develop because of degeneration of certain groups of nerve cells in the spinal cord.
Johnny Cash last performed on July 5, 2003. He was diagnosed in 1997 with Shy-Drager syndrome a neurodegenerative disease. He died on September 12, 2003.
.drug treatment includes fludrocortisone, indomethacin, nonsteroidal anti-inflammatory drugs, beta blockers, central stimulants, and other medications. a liberal salt diet. Occasionally, a pacemaker, gastrostomy, or tracheostomy may be needed.
no